Pre-market Hot Trades in US Stocks

Lion Holdings pre-market rose 4.65%. Based on recent key news:

1. On July 28, Lion Holdings rose 30.15% during the session, currently reported at $1.185. This significant increase may be related to short-term speculative behavior in the market regarding its stock.

2. On July 28, HRT Financial LP adjusted its holdings in Lion Holdings, purchasing 27,702 shares at a price of $0.95 on July 24, indicating continued interest in the stock.

3. On July 28, Spark analysts rated Lion Holdings as underperforming due to weak financial performance and technical pressure, leading to a pessimistic outlook on its future performance. The market is cautious about Lion Holdings, facing significant technical pressure.

NIP pre-market rose 4.55%, with no significant news recently. Trading is active, with clear capital flows. Considering sector and industry trends, the stock shows significant volatility, and specific reasons need further observation.

Top Gainers in Pre-market US Stocks

Nuwellis pre-market rose 102.17%. Based on recent key news:

1. On July 27, Nuwellis announced a preliminary revenue growth of 14% for the second quarter of 2026, driving a significant rise in stock price. The company stated that this growth is mainly attributed to the commercial success of the Aquadex ultrafiltration platform.

2. On July 27, Nuwellis announced a 20% year-on-year revenue growth for the first half of 2026, further boosting market confidence. The company plans to release its complete second-quarter financial report on August 13.

3. On July 27, Nuwellis's preliminary financial results showed significant growth potential, attracting investor attention and leading to a substantial pre-market rise in stock price. The medical device industry is experiencing strong growth, with high market interest.

T3 Defense pre-market rose 82.74%. Based on recent key news:

1. On July 29, T3 Defense completed a 1-for-125 reverse stock split, reducing the float to 1.12 million shares, triggering a technical short squeeze. At the same time, the company made operational progress in its Project 35 in the anti-drone technology field and achieved contract delivery, with X S.E. Security and Defense Ltd. acquiring 16.67% of the company’s equity in exchange for Project 35 rights, boosting market confidence.

2. On July 28, T3 Defense's subsidiary completed the delivery of an automated composite material production line to a major Israeli manufacturer, further expanding its influence in the high-demand anti-drone technology field, attracting investor interest.

3. On July 28, SEC Schedule 13D filings showed that X S.E. Security and Defense Ltd. acquired 16.67% of T3 Defense shares, further enhancing market confidence The demand for anti-drone technology is growing, and the market is active.

China Su Xuan Tang Pharmaceutical is up 60.38% in pre-market trading, with no significant news recently. Trading is active, and capital flows are evident. Considering the sector and industry trends, the stock shows significant volatility, and the specific reasons need further observation